Quick Answer
Citius Pharmaceuticals, Inc. reported Total Assets of $130.94 million for the year ending 2025.
- Citius Pharmaceuticals, Inc. showed an increase of +12.2% in Total Assets from 2024 to 2025.
- This data is from Citius Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on December 23, 2025.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $65.00 | Q4 2011: $216.00 | Q1 2012: $17.00 | Q2 2012: $171.00 | Q4 2012: $99.00 | Q2 2013: $27.00 | Q3 2013: $0.00 | Q4 2013: $6.0 thousand | Q1 2014: $0.00 | Q2 2014: $0.00 | Q4 2014: $822.6 thousand | Q1 2015: $765.8 thousand | Q2 2015: $962.3 thousand | Q4 2015: $346.9 thousand | Q1 2016: $24.78 million | Q2 2016: $23.01 million | Q4 2016: $21.48 million | Q1 2017: $21.33 million | Q2 2017: $21.57 million | Q4 2017: $28.47 million | Q1 2018: $26.06 million | Q2 2018: $23.83 million | Q4 2018: $28.08 million | Q1 2019: $24.24 million | Q2 2019: $25.54 million | Q4 2019: $24.98 million | Q1 2020: $26.49 million | Q2 2020: $38.40 million | Q4 2020: $35.31 million | Q1 2021: $134.67 million | Q2 2021: $146.59 million | Q4 2021: $137.52 million | Q1 2022: $127.79 million | Q2 2022: $120.32 million | Q4 2022: $111.71 million | Q1 2023: $104.24 million | Q2 2023: $110.40 million | Q4 2023: $97.40 million | Q1 2024: $90.71 million | Q2 2024: $97.09 million | Q4 2024: $120.70 million | Q1 2025: $121.48 million | Q2 2025: $127.68 million | Q3 2025: $130.94 million | Q4 2025: $140.39 million.
- Over the full 16 years of available data (2010 to 2025), Citius Pharmaceuticals, Inc.'s Total Assets has grown by 5,237,421.0%.
- Historical annual values: Fiscal year 2025: $130.94 million | Fiscal year 2024: $116.65 million | Fiscal year 2023: $103.61 million | Fiscal year 2022: $114.00 million | Fiscal year 2021: $142.43 million | Fiscal year 2020: $43.77 million | Fiscal year 2019: $36.75 million | Fiscal year 2018: $31.05 million | Fiscal year 2017: $24.42 million | Fiscal year 2016: $21.95 million | Fiscal year 2015: $741.5 thousand | Fiscal year 2014: $1.56 million | Fiscal year 2013: $0.00 | Fiscal year 2012: $135.00 | Fiscal year 2011: $212.00 | Fiscal year 2010: $2.5 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: